Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 04, 2022

Addition of Venetoclax to a FLAG-IDA–Based Protocol for Patients With AML

Annals of Hematology


Additional Info

Annals of Hematology
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis
Ann Hematol 2022 Aug 01;101(8)1719-1726, O Wolach, A Frisch, L Shargian, M Yeshurun, A Apel, V Vainstein, Y Moshe, S Shimony, O Amit, Y Bar-On, Y Ofran, P Raanani, B Nachmias, R Ram

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading